Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait

被引：0
作者：
Jasem AL-Hashel
Samar F. Ahmed
Raed Behbehani
Raed Alroughani
机构：
[1] Ibn Sina Hospital,Department of Neurology
[2] Kuwait University,Faculty of Medicine
[3] Minia University,Department of Neurology and Psychiatry
[4] Al-Bahar Eye Center,Department of Ophthalmology
[5] Dasman Diabetes Institute,Neurology Clinic
[6] Amiri Hospital,Division of Neurology, Department of Medicine
来源：
CNS Drugs | 2014年 / 28卷
关键词：
Multiple Sclerosis; Expand Disability Status Scale; Natalizumab; Glatiramer Acetate; Fingolimod;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 824
页数：7
相关论文
共 50 条
  • [31] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Cavit Boz
    Serkan Ozakbas
    Murat Terzi
    Rana Karabudak
    Serhan Sevim
    Recai Turkoglu
    Aysun Soysal
    Belgin Petek Balcı
    Hüsnü Efendi
    Ömer Faruk Turan
    Nur Yüceyar
    Mehmet Fatih Yetkin
    Serap Zengin Karahan
    Meltem Demirkıran
    Sibel Guler
    Kadriye Agan
    Nefati Kıylıoğlu
    Cavid Baba
    Asli Tuncer
    Mesrure Köseoğlu
    Neurological Sciences, 2023, 44 : 2121 - 2129
  • [32] Multiple sclerosis and related disorders: Short report peripheral vascular events in a real-world cohort of multiple sclerosis patients using Fingolimod
    Pelayo, Carolina
    Ciampi, Ethel
    Uribe-San-Martin, Reinaldo
    Soler, Bernardita
    Reyes, Ana
    Vergara, Elizabeth
    Carcamo, Claudia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [33] OCT Analysis in Patients with Relapsing-Remitting Multiple Sclerosis during Fingolimod Therapy: 2-Year Longitudinal Retrospective Study
    Rossi, Settimio
    Gesualdo, Carlo
    Gallo, Antonio
    Melillo, Paolo
    Martines, Francesco
    Colucci, Raffaella
    D'Ambrosio, Alessandro
    Tedeschi, Gioacchino
    Simonelli, Francesca
    APPLIED SCIENCES-BASEL, 2020, 10 (20): : 1 - 9
  • [34] Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
    Johannes Lorscheider
    Pascal Benkert
    Carmen Lienert
    Peter Hänni
    Tobias Derfuss
    Jens Kuhle
    Ludwig Kappos
    Özgür Yaldizli
    Journal of Neurology, 2021, 268 : 941 - 949
  • [35] Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patients
    Cannizzaro, Miryam
    Ferre, Laura
    Clarelli, Ferdinando
    Giordano, Antonino
    Sangalli, Francesca
    Colombo, Bruno
    Comi, Giancarlo
    Moiola, Lucia
    Martinelli, Vittorio
    Filippi, Massimo
    Esposito, Federica
    JOURNAL OF NEUROLOGY, 2022, 269 (10) : 5596 - 5605
  • [36] Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study
    Ilki, Canan Duman
    Gunduz, Tuncay
    Kurtuncu, Murat
    Yapici, Zuhal
    Sencer, Serra
    Eraksoy, Mefkure
    TURKISH JOURNAL OF NEUROLOGY, 2020, 26 (01) : 34 - 38
  • [37] Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
    Boziki, Marina
    Bakirtzis, Christos
    Giantzi, Virginia
    Sintila, Styliani-Aggeliki
    Kallivoulos, Stylianos
    Afrantou, Theodora
    Nikolaidis, Ioannis
    Ioannidis, Panagiotis
    Karapanayiotides, Theodoros
    Koutroulou, Ioanna
    Parissis, Dimitrios
    Grigoriadis, Nikolaos
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [38] Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients
    F. Esposito
    L. Ferrè
    F. Clarelli
    M. A. Rocca
    G. Sferruzza
    L. Storelli
    M. Radaelli
    F. Sangalli
    L. Moiola
    B. Colombo
    F. Martinelli Boneschi
    G. Comi
    M. Filippi
    V. Martinelli
    Journal of Neurology, 2018, 265 : 896 - 905
  • [39] Natalizumab: A guide to its use in relapsing-remitting multiple sclerosis
    Keating G.M.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2014, 30 (2) : 48 - 54
  • [40] Cardiac repolarization during fingolimod treatment in patients with relapsing-remitting multiple sclerosis
    Laiho, Aapo
    Laitinen, Tiina M.
    Hartikainen, Paivi
    Hartikainen, Juha E. K.
    Laitinen, Tomi P.
    Simula, Sakari
    BRAIN AND BEHAVIOR, 2018, 8 (02):
12345